Perrigo Company plc, formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. Its operating segments are Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. Its CHC segment sells OTC store brand products, including cough, cold, allergy and sinus, Vitamins, Minerals and Supplements (VMS), animal health and diagnostic products. Its BCH segment develops, manufactures, markets and distributes various European OTC brands in the natural health and VMS, cough and allergy, smoking cessation and anti-parasite categories, among others. Its Rx segment develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs. Its Specialty Sciences segment consists of royalties received from assets focused on the management of multiple sclerosis (Tysabri). Its Other segment consists of active pharmaceutical ingredients (API) business.